Caroline Robert

Title: Caroline Robert: Innovator in Immunotherapy

Introduction

Caroline Robert is a prominent inventor based in Fontenay-aux-Roses, France. She has made significant contributions to the field of immunotherapy, particularly in methods for predicting the sensitivity of cancer patients to treatment. Her innovative approach aims to enhance the effectiveness of immunotherapeutic interventions.

Latest Patents

Caroline Robert holds 1 patent titled "Methods for predicting the sensitivity of a subject to immunotherapy." This invention relates to a method of assessing, predicting, or monitoring the sensitivity of a subject with a tumor or cancer to an immunotherapeutic molecule that acts on the subject's T cells. The method involves determining the expression level of soluble CD25 (sCD25) in a biological sample from the subject and comparing it to a reference expression level. This comparison helps assess whether the subject is responsive or resistant to the immunotherapeutic molecule.

Career Highlights

Caroline Robert is affiliated with the Institut Gustave Roussy, a leading cancer research institution. Her work focuses on improving cancer treatment through innovative methodologies that enhance patient outcomes.

Collaborations

Some of her notable coworkers include Dalil Hannani and Laurence Zitvogel, who contribute to her research efforts in the field of immunotherapy.

Conclusion

Caroline Robert's contributions to immunotherapy exemplify the vital role of innovation in advancing cancer treatment. Her patented methods provide valuable insights that can lead to more effective therapies for patients.